Inactive Instrument

News SourcingLink.net, Inc. OTC Bulletin Board

Equities

US8361714053

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

Oncology Pharma : Conducting Interviews and Presentations with Investors to Pursue Next Steps to Forward The Development Process of Nanoemulsion Drug Delivery System	22-07-12	PU
Oncology Pharma : Conducting All The Preparations to Take Steps to Forward The Development Process of Nanoemulsion Drug Delivery System	22-06-29	PU
Oncology Pharma : Financial Statements (Unaudited) for the year ended March 31, 2022	22-06-06	PU
Oncology Pharma : Financial Statements for the period ended December 31, 2021	22-02-14	PU
Oncology Pharma : Disclosure Statement for the period ended December 31, 2021	22-02-14	PU
Oncology Pharma Inc :.	21-07-20	AQ
Oncology Pharma : Has Provided Initial Funding to NanoSmart Pharmaceuticals to Conduct Feasibility Studies for Initial Phases of IND-Enabling Activities	21-03-31	AQ
NanoSmart Pharmaceuticals, Inc. announced that it has received funding from Oncology Pharma Inc.	21-03-30	CI
Oncology Pharma : Reveals Strategic Plans for Company Growth and Focus	21-03-16	AQ
Oncology Pharma : Vetting CROs to Develop Research Plan and Indications for Recently Licensed Cancer Combination Therapy	21-03-10	AQ
Oncology Pharma, Inc. Vetting CROs to Develop Research Plan and Indications for Recently Licensed Cancer Combination Therapy	21-03-10	CI
Oncology Pharma : Moves to Fund Lead Drug Formulation & IND-Enabling Studies	21-03-04	AQ
Oncology Pharma Inc. Moves to Fund Lead Drug Formulation & IND-Enabling Studies	21-03-04	CI
Oncology Pharma Signs Worldwide Licensing Agreement with Sybleu, Inc. for Commercialization of Chemotherapeutic Agent in Combination with a Bioactive Immunostimulatory Agent	21-02-26	GL
Oncology Pharma Signs Worldwide Licensing Agreement with Sybleu, Inc. for Commercialization of Chemotherapeutic Agent in Combination with a Bioactive Immunostimulatory Agent	21-02-26	CI
Oncology Pharma : Extends Licensing Agreement with NanoSmart Pharmaceuticals, Inc. for Veterinary Oncology	21-02-22	AQ
Oncology Pharma Extends Licensing Agreement with Nanosmart Pharmaceuticals, Inc. for Veterinary Oncology	21-02-22	CI
Oncology Pharma : is Pleased to Welcome New Chairman to Its Scientific Advisory Board	21-02-16	AQ
Oncology Pharma Inc. Announces Henry Smith as New Chairman to Its Scientific Advisory Board	21-02-16	CI
Oncology Pharma : Renews Licensing Agreement With Ribera Solutions LLC for Its Connect2Med Clinical Trials Platform	21-02-09	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News SourcingLink.net, Inc. OTC Bulletin Board

Equities

US8361714053

Summary

Filters